mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.5 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.0077 |
0.9 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.06 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |